Cargando…
Functional expression of a single-chain antibody to ErbB-2 in plants and cell-free systems
BACKGROUND: Aberrant signaling by ErbB-2 (HER 2, Neu), a member of the human Epidermal Growth Factor (EGF) receptor family, is associated with an aggressive clinical behaviour of carcinomas, particularly breast tumors. Antibodies targeting the ErbB-2 pathway are a preferred therapeutic option for pa...
Autores principales: | Galeffi, Patrizia, Lombardi, Alessio, Pietraforte, Immacolata, Novelli, Flavia, Di Donato, Monica, Sperandei, Maria, Tornambé, Andrea, Fraioli, Rocco, Martayan, Aline, Natali, Pier Giorgio, Benevolo, Maria, Mottolese, Marcella, Ylera, Francisco, Cantale, Cristina, Giacomini, Patrizio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1592514/ https://www.ncbi.nlm.nih.gov/pubmed/17010186 http://dx.doi.org/10.1186/1479-5876-4-39 |
Ejemplares similares
-
Antigenic modulation of metastatic breast and ovary carcinoma cells by intracavitary injection of IFN-alpha.
por: Giacomini, P., et al.
Publicado: (1992) -
In vivo evidence of htid suppressive activity on ErbB-2 in breast cancers over expressing the receptor
por: Kurzik-Dumke, Ursula, et al.
Publicado: (2010) -
Modulation of ErbB2 Blockade in ErbB2-Positive Cancers: The Role of ErbB2 Mutations and PHLDA1
por: Li, Guangyuan, et al.
Publicado: (2014) -
Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer
por: Wolfson, Eya, et al.
Publicado: (2016) -
Endocrine resistance in breast cancer: new roles for ErbB3 and ErbB4
por: Sutherland, Robert L
Publicado: (2011)